Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP6803789B2 - Patch medicated base material - Google Patents
[go: Go Back, main page]

JP6803789B2 - Patch medicated base material - Google Patents

Patch medicated base material Download PDF

Info

Publication number
JP6803789B2
JP6803789B2 JP2017066487A JP2017066487A JP6803789B2 JP 6803789 B2 JP6803789 B2 JP 6803789B2 JP 2017066487 A JP2017066487 A JP 2017066487A JP 2017066487 A JP2017066487 A JP 2017066487A JP 6803789 B2 JP6803789 B2 JP 6803789B2
Authority
JP
Japan
Prior art keywords
film
base material
woven fabric
fabric layer
resin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017066487A
Other languages
Japanese (ja)
Other versions
JP2018168090A5 (en
JP2018168090A (en
Inventor
武田 茂樹
茂樹 武田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Vilene Co Ltd
Original Assignee
Japan Vilene Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Vilene Co Ltd filed Critical Japan Vilene Co Ltd
Priority to JP2017066487A priority Critical patent/JP6803789B2/en
Publication of JP2018168090A publication Critical patent/JP2018168090A/en
Publication of JP2018168090A5 publication Critical patent/JP2018168090A5/ja
Application granted granted Critical
Publication of JP6803789B2 publication Critical patent/JP6803789B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Nonwoven Fabrics (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Laminated Bodies (AREA)

Description

本発明は、種々の薬剤を含む粘着剤を塗布形成するための貼付薬用基材に関し、特にフィルムと不織布層との複合構造を有し、基材への薬剤吸着が少なく、かつ貼付薬としての密封療法に効果的な基材に関する。 The present invention relates to a patching medicinal base material for applying and forming an adhesive containing various chemicals, and particularly has a composite structure of a film and a non-woven fabric layer, has less drug adsorption to the base material, and serves as a patch. Regarding substrates that are effective for sealing therapy.

基材に薬効成分を塗布した貼付薬は、皮膚に貼付するのみで効果を有する利便性、或いは、注射に比べて侵襲性が低いことから、広く普及している。当初は消炎鎮痛を薬効とするものが主流であったが、現在では狭心症や喘息に対応するための血管拡張成分若しくは気管支拡張成分を塗布配合したものが使用されている。周知の通り、貼付薬は、薬効成分及びこれを安定化するための薬剤、皮膚に貼付するための粘着剤を膏体として基材に塗布して構成される。貼付された部位では、皮膚から分泌される汗に由来する水分、または膏体に含まれる水分、アルコールなどの補助成分が体温で皮膚を構成する角質に浸透して一種の蒸れを生じる。このような状態にある角質では、薬効成分の体内への透過性或いは浸透性が高まると考えられており、所謂、密封療法(以下、ODTと称する場合がある)として知られている。 Patches in which a medicinal ingredient is applied to a base material are widely used because they are convenient to have an effect only by sticking to the skin or are less invasive than injections. Initially, those with anti-inflammatory and analgesic effects were the mainstream, but nowadays, those with a vasodilator or bronchodilator applied to treat angina and asthma are used. As is well known, a patch is composed of a medicinal ingredient, a drug for stabilizing the drug, and an adhesive for sticking to the skin, which are applied to a base material as a plaster. At the site of application, water derived from sweat secreted from the skin, water contained in the plaster, and auxiliary components such as alcohol permeate into the keratin that constitutes the skin at body temperature, causing a kind of stuffiness. In the keratin in such a state, it is considered that the permeability or permeability of the medicinal ingredient into the body is enhanced, and it is known as so-called sealing therapy (hereinafter, may be referred to as ODT).

このような蒸れが重要なファクターであり、薬効成分の透過量を極大化するためには、基材の透湿度をコントロールする必要がある。つまり、人の安静時における不感蒸泄は600〜700g/m/日程度と言われるが、基材の透湿性が高すぎる場合、上記蒸れは生じず、基材を通して水分が外気に放出され易くなり、効果的な薬剤浸透を図ることが難しくなる。 Such stuffiness is an important factor, and in order to maximize the permeation amount of the medicinal ingredient, it is necessary to control the moisture permeation of the base material. That is, it is said that insensitive evaporation of a person at rest is about 600 to 700 g / m 2 / day, but if the moisture permeability of the base material is too high, the above stuffiness does not occur and water is released to the outside air through the base material. It becomes easy and it becomes difficult to achieve effective drug penetration.

上述した透湿度に着目した技術として、例えば特開2005−343125号公報(以下、特許文献1)では、概略的な断面により示す図1のように、ポリアミド系樹脂からなる不織布11の両面に、ポリアミドエラストマー系樹脂からなる樹脂シート13を積層してなる不織布積層体15が提案されている。当該公報技術は不織布積層体15に粘着剤層17を塗布形成して用いられるが、従前、救急絆創膏等の皮膚用貼付剤の多くが、ポリ塩化ビニル(PVC)、ポリエチレン(PE)、ポリプロピレン(PP)等のフィルムに粘着加工を施したものでは素材の透湿性に乏しく、皮膚の蒸れを引き起こすという点に着目している。従って、提案に係る不織布積層体15の透湿度は800g/m・24hr以上(以下、本明細書における透湿度の単位は当該公報技術と同義の「g/m/日」として統一表記する)が好ましいと規定され、好適態様を示す実施例欄では、前述した不感蒸泄を大幅に超える3000〜3600g/m/日の透湿度を有する不織布積層体が比較検討されている。このため、前述した不感蒸泄による発生水分量に較べて高い透湿度を基材に与えることで、貼着力の低下防止を図り得るとの開示がある。さらに、貼付時の身体の動きに違和感なく対応するためには、基材となる不織布積層体15の剛軟度(カンチレバー法)は15mm以上で50mm以下とするのが好ましく、かつ、基材がカールして両端の粘着剤塗布面同士が粘着するトラブルも防止し得る。尚、当該特許文献1では、このように剛軟度を選択することによってカールを抑制する特性を「自己支持性が良い」と表現されている。 As a technique focusing on the above-mentioned moisture permeability, for example, in Japanese Patent Application Laid-Open No. 2005-343125 (hereinafter, Patent Document 1), as shown in FIG. 1 shown by a schematic cross section, both surfaces of the non-woven fabric 11 made of a polyamide resin are used. A non-woven fabric laminate 15 formed by laminating a resin sheet 13 made of a polyamide elastomer resin has been proposed. The publication technology is used by applying an adhesive layer 17 to a non-woven fabric laminate 15, but conventionally, most skin patches such as emergency adhesive plasters are made of polyvinyl chloride (PVC), polyethylene (PE), polypropylene ( We are paying attention to the fact that a film such as PP) that has been subjected to adhesive processing has poor moisture permeability of the material and causes stuffiness of the skin. Therefore, the moisture permeability of the nonwoven fabric laminate 15 in accordance with the proposed 800g / m 2 · 24hr or more (hereinafter, the unit of the moisture permeability herein unifies expressed as "g / m 2 / day" of the publication art synonymous ) Is preferable, and in the Example column showing the preferred embodiment, a non-woven fabric laminate having a moisture permeability of 3000 to 3600 g / m 2 / day, which greatly exceeds the above-mentioned insensitive evaporation, is compared and examined. Therefore, there is a disclosure that it is possible to prevent a decrease in the adhesive force by giving the base material a moisture permeability higher than the amount of water generated by the insensitive evaporation described above. Further, in order to cope with the movement of the body at the time of sticking without discomfort, the stiffness (cantilever method) of the non-woven fabric laminate 15 as the base material is preferably 15 mm or more and 50 mm or less, and the base material is It is also possible to prevent the trouble of curling and the adhesive-coated surfaces at both ends sticking to each other. In Patent Document 1, the property of suppressing curl by selecting the rigidity and softness in this way is expressed as "good self-supporting property".

上述した説明からも理解できるように、特許文献1は、主として絆創膏用途に適した基材(本明細書では、貼付薬の粘着成分を除く構成成分を単に「基材」として包括的に表す。)を提案するものであって、蒸れによる薬剤の皮膚透過性を利用するODT効果の達成を意図した技術ではない。これに対して、本出願人は、例えば特開2008−163538号(以下、特許文献2)で、ポリエステルからなる厚さが6μmを超えるフィルムの少なくとも一方の面に、未延伸ポリエステル繊維を含む繊維ウエブを熱接着してなる不織布層が形成された貼付剤用複合不織布を提案している。図2は前述図1と同様に示す断面図であり、この技術では、薬剤吸着の少ないポリエステルフィルム21と、これに加熱接着された不織布層23とで基材となる複合不織布層25を構成する。次いで薬剤を含む粘着剤27を不織布層23側に塗布形成することで貼付剤として使用される。当該文献技術によれば、複合不織布層25を調製する加熱接着工程を経た後、基材自体が有する単位面積当たりの結晶化熱を3.0×10−2J/cm以下とすることによって、未延伸ポリエステル繊維の薬剤吸着能を解消し、しかも、粘着剤27に対する不織布層23の投錨性を付与することができる。尚、同図では、不織布層23の構成繊維が粘着剤27の層領域に混在するため、その界面を破線で示している。この複合不織布層25からなる基材を構成する各構成成分の好適形態は後段で詳述するが、ポリエステルフィルムの厚さは6〜25μm、不織布層の面密度は4〜25g/mとし、基材としての厚さは20〜100μmと開示している。また本明細書では、「ポリエステルフィルム21」と「不織布層23」とが熱接着された後の2層からなる構成成分、換言すれば特許文献2における基材相当の構成成分を「複合不織布層25」と称する。 As can be understood from the above description, Patent Document 1 comprehensively represents a base material mainly suitable for adhesive plaster applications (in the present specification, constituent components excluding the adhesive component of the patch are simply referred to as "base material". ), But is not a technique intended to achieve the ODT effect utilizing the skin permeability of the drug due to stuffiness. On the other hand, in Japanese Patent Application Laid-Open No. 2008-163538 (hereinafter referred to as Patent Document 2), the applicant has stated that fibers containing unstretched polyester fibers on at least one surface of a film made of polyester and having a thickness of more than 6 μm. We are proposing a composite non-woven fabric for patches on which a non-woven fabric layer formed by heat-bonding a web is formed. FIG. 2 is a cross-sectional view shown in the same manner as in FIG. 1 described above. In this technique, a polyester film 21 having less chemical adsorption and a nonwoven fabric layer 23 heat-bonded to the polyester film 21 constitute a composite nonwoven fabric layer 25 as a base material. .. Next, the pressure-sensitive adhesive 27 containing the drug is applied and formed on the non-woven fabric layer 23 side to be used as a patch. According to the literature technology, after the heat bonding step of preparing the composite non-woven fabric layer 25, the heat of crystallization per unit area of the base material itself is set to 3.0 × 10-2 J / cm 2 or less. It is possible to eliminate the drug-adsorbing ability of the unstretched polyester fiber and to impart the anchoring property of the non-woven fabric layer 23 to the pressure-sensitive adhesive 27. In the figure, since the constituent fibers of the non-woven fabric layer 23 are mixed in the layer region of the pressure-sensitive adhesive 27, the interface thereof is shown by a broken line. The preferred form of each component constituting the base material composed of the composite non-woven fabric layer 25 will be described in detail later, but the thickness of the polyester film is 6 to 25 μm, and the surface density of the non-woven fabric layer is 4 to 25 g / m 2 . The thickness of the substrate is disclosed as 20 to 100 μm. Further, in the present specification, the constituent component composed of two layers after the "polyester film 21" and the "nonwoven fabric layer 23" are heat-bonded, in other words, the constituent component corresponding to the base material in Patent Document 2 is referred to as the "composite nonwoven fabric layer". It is called "25".

特開2005−343125号公報([特許請求の範囲]、[0002]、[0006]、[0020]、[0046]、[実施例]、[図1]など)Japanese Unexamined Patent Publication No. 2005-343125 ([Claims], [0002], [0006], [0020], [0046], [Examples], [Fig. 1], etc.) 特開2008−163538号公報([特許請求の範囲]、[0012]、[0024]〜[0027]、など)Japanese Unexamined Patent Publication No. 2008-163538 ([Claims], [0012], [0024] to [0027], etc.)

上述した従来の基材は、何れも粘着剤を伴って使用される。この際、基材には粘着剤の塗布面方向に所定の応力が加わり、所謂、カール現象が生じる場合がある。例えば、特許文献1の技術では、基材15の厚さ方向で不織布11を中心とした対称な層構造を有するため、基材15が十分な曲げ硬さを持っている場合には粘着剤層17に由来する応力との相対関係でカールを生じることが少ない。これに対して、特許文献2の技術では、基材となる複合不織布25が非対称な2層構成であること、並びに、20〜100μm程度の小さな厚さであることから、粘着剤27の塗布形成後に基材25との間で応力差を生じ、カールを生じる場合が有った。 All of the above-mentioned conventional substrates are used with an adhesive. At this time, a predetermined stress is applied to the base material in the direction of the coating surface of the adhesive, and a so-called curl phenomenon may occur. For example, in the technique of Patent Document 1, since the base material 15 has a symmetrical layer structure centered on the non-woven fabric 11 in the thickness direction, when the base material 15 has sufficient bending hardness, the pressure-sensitive adhesive layer Curling is less likely to occur in relation to the stress derived from 17. On the other hand, in the technique of Patent Document 2, since the composite nonwoven fabric 25 as the base material has an asymmetric two-layer structure and has a small thickness of about 20 to 100 μm, the pressure-sensitive adhesive 27 is applied and formed. Later, a stress difference was generated with the base material 25, which may cause curling.

本出願に係る発明者は、上述した特許文献2に係る技術を基に、薬剤吸着の少ないポリエステルフィルムの厚さを増すことにより、カール低減が可能な基材設計を検討した。しかしながら、図2に示す粘着剤塗布後にポリエステルフィルム21の面側に凹となるカール(以下、凹型カールと称する)が強く表れ、これと異なる粘着剤27面側に凸となって、貼付剤とした場合に、その周縁が貼付対象から剥離する場合が有った。この現象は、高価で高濃度の薬剤を配合した粘着剤の場合、剤型が1cm角以下と小さいことから、実用に供するのは極めて不利となる場合が多く、さらには、衣服との擦れにより貼着した製剤が剥がれ落ちる場合もある。また、前述のとおりODT効果を期待するには基材の透湿性が重要な要素である。一例として、厚さ12μmのポリエステルフィルムの透湿性は50g/m/日以上であって、ODTを有効に機能させるのに必要とされる10g/m/日以下の条件を満足することが難しいという問題点も有った。本発明は上述した従来の問題点に鑑みなされたものであって、基材表面側の凹型カールを低減させ、かつ、上述した実用に十分な透湿性を発揮する基材を提供することを目的とする。 Based on the technique according to Patent Document 2 described above, the inventor of the present application has studied a base material design capable of reducing curl by increasing the thickness of a polyester film having less drug adsorption. However, after the pressure-sensitive adhesive shown in FIG. 2 is applied, a concave curl (hereinafter referred to as a concave curl) appears strongly on the surface side of the polyester film 21, and becomes convex on the 27-side surface side of the pressure-sensitive adhesive, which is different from this, and becomes a patch. In that case, the peripheral edge may be peeled off from the object to be attached. This phenomenon is often extremely disadvantageous for practical use because the dosage form of an adhesive containing an expensive and high-concentration drug is as small as 1 cm square or less, and further, it is caused by rubbing against clothes. The applied formulation may come off. Further, as described above, the moisture permeability of the base material is an important factor in expecting the ODT effect. As an example, a 12 μm thick polyester film may have a moisture permeability of 50 g / m 2 / day or more and satisfy the conditions of 10 g / m 2 / day or less required for the ODT to function effectively. There was also the problem that it was difficult. The present invention has been made in view of the above-mentioned conventional problems, and an object of the present invention is to provide a base material that reduces concave curl on the surface side of the base material and exhibits the above-mentioned practically sufficient moisture permeability. And.

この目的の達成を図るため、本発明の構成によれば、厚さが6〜25μmのポリエチレンテレフタレートフィルムの一方の表面に、未延伸ポリエステル繊維を含む繊維ウエブを熱接着してなる不織布層が設けられた複合不織布層を含み、かつ、この複合不織布層の単位面積当たりの結晶化熱が3.0×10−2J/cm以下である貼付薬用基材であって、上述したフィルムの他方の面にラミネートフィルムを配し、前記ラミネートフィルムは、環状オレフィン系コポリマー樹脂と低密度ポリエチレン樹脂とをブレンドした単層フィルム、ポリエチレン樹脂からなる単層フィルム、ポリ塩化ビニリデン樹脂からなる単層フィルム、低密度ポリエチレン樹脂と直鎖状低密度ポリエチレン樹脂とを積層構成した複合フィルムから選択される、厚さが25μm以下のラミネートフィルムであって、KES法の純曲げ試験(KES−FB2法)で求めた凹型応力が凸型応力よりも大きい構成となっている。この「凹型応力」とは、基材のラミネートフィルムを内側として曲げようとする際に必要な応力相当の外力を言い、「凸型応力」とは基材の不織布層を内側として曲げようとする際に必要な外力を言う。尚、この2種類の外力は、測定によって得られた値が大きいほど、明示した方向に曲げ固いことを表し、JISL1096に規定のカンチレバー法による剛軟度のような、基材の自重に依存する静的な測定値とは異なり、反復的な屈曲操作で観測可能な動的な曲げ固さが、凹型カール若しくは凸型カールの、何れを生じ易い傾向があるのかを示すための値である。
In order to achieve this object, according to the configuration of the present invention, a non-woven layer formed by heat-bonding a fiber web containing unstretched polyester fibers is provided on one surface of a polyethylene terephthalate film having a thickness of 6 to 25 μm. A patch medicinal base material containing the composite non-woven fabric layer and having a heat of crystallization of 3.0 × 10-2 J / cm 2 or less per unit area of the composite non-woven fabric layer, which is the other of the above-mentioned films. A laminated film is arranged on the surface of the above, and the laminated film is a single-layer film in which a cyclic olefin-based copolymer resin and a low-density polyethylene resin are blended, a single-layer film made of polyethylene resin, and a single-layer film made of polyvinylidene chloride resin. A laminated film having a thickness of 25 μm or less, which is selected from a composite film composed of a low-density polyethylene resin and a linear low-density polyethylene resin laminated, and is determined by a pure bending test (KES-FB2 method) of the KES method. The concave stress is larger than the convex stress. This "concave stress" means an external force equivalent to the stress required when trying to bend the laminated film of the base material as the inside, and "convex stress" means bending the non-woven fabric layer of the base material as the inside. The external force required at the time. The larger the value obtained by the measurement, the more the two types of external forces are bent and hardened in the specified direction, and depend on the weight of the base material, such as the flexibility by the cantilever method specified in JIS L1096. Unlike the static measurement value, it is a value for indicating whether the dynamic bending hardness observable by the repetitive bending operation tends to cause concave curl or convex curl.

また、本発明の実施に当たり、上述した貼付薬用基材の温度40℃、相対湿度90%の条件下で測定される透湿度は40(g/m/日)以下である。この値は前述した不感蒸泄による水分量の20分の1以下程度の湿度しか透過しないものである。
Also, per the practice of the present invention, the temperature 40 ° C. of the patch medicinal substrates described above, the moisture permeability being measured under the conditions of a relative humidity of 90% is hereinafter 40 (g / m 2 / day). This value permeates only humidity of about 1/20 or less of the water content due to the above-mentioned insensitive evaporation.

本発明の技術を適用することにより、粘着剤を塗布形成した後であっても、基材表面側への凹型カールを軽減し、しかも、実用に十分な透湿性を発揮することによって、ODT効果に優れた基材を提供することができる。 By applying the technique of the present invention, even after the pressure-sensitive adhesive is applied and formed, the concave curl on the surface side of the base material is reduced, and the ODT effect is exhibited by exhibiting sufficient moisture permeability for practical use. It is possible to provide an excellent base material.

背景技術を説明するため、貼付剤の概略断面によって示す説明図。Explanatory drawing which shows by schematic cross section of a patch for explaining a background technique. 他の背景技術の好適形態を説明するため、図1と同様に示す説明図。An explanatory diagram shown in the same manner as in FIG. 1 for explaining a preferable form of another background technique. 本発明の好適形態を説明するため、上述の各図と同様に示す説明図である。In order to explain the preferred embodiment of the present invention, it is explanatory drawing which shows in the same manner as each above-mentioned figure.

以下、図を参照して、本発明の好適形態につき説明する。図3は、図2と同様に概略断面により示す説明図であり、同様の機能を有する構成成分には同一の符号及びハッチングを付す。 Hereinafter, preferred embodiments of the present invention will be described with reference to the drawings. FIG. 3 is an explanatory view showing a schematic cross section as in FIG. 2, and components having the same function are designated by the same reference numerals and hatches.

まず、特許文献2に開示されるとおり、ポリエステルからなるフィルム21には周知のポリエステル系樹脂を種々に選択でき、芳香族ジカルボン酸を主な酸成分とし、アルキレングリコールを主なグリコール成分とし得る。具体的には、芳香族ジカルボン酸として、テレフタル酸、イソフタル酸、ナフタレンジカルボン酸、ジフェノキシエタンジカルボン酸、ジフェニルジカルボン酸、ジフェニルエーテルジカルボン酸、ジフェニルスルホンジカルボン酸、ジフェニルケトンジカルボン酸等が挙げられる。また、アルキレングリコールとしては、エチレングリコール、トリメチレングリコール、テトラメチレングリコール、ペンタメチレングリコール、ヘキサメチレングリコール、ヘキシレングリコール等が知られている。これら重合成分の組み合わせとして、特に化学的に安定なテレフタル酸とエチレングリコールとの共重合体を用いることができる。基材の工程適性の観点から、係る共重合体からなるポリエステルフィルムは少なくとも1軸延伸されていることが望ましく、市販されているものとして「テトロンフィルム」(帝人デュポンフィルム(株)製,商品名)や「ルミラー」(東レ(株)製,商品名)のような2軸延伸フィルムを採用することができる。 First, as disclosed in Patent Document 2, various well-known polyester-based resins can be selected for the polyester film 21, and aromatic dicarboxylic acids can be the main acid component and alkylene glycol can be the main glycol component. Specific examples of the aromatic dicarboxylic acid include terephthalic acid, isophthalic acid, naphthalenedicarboxylic acid, diphenoxyetanedicarboxylic acid, diphenyldicarboxylic acid, diphenyletherdicarboxylic acid, diphenylsulfonedicarboxylic acid, and diphenylketonedicarboxylic acid. Further, as the alkylene glycol, ethylene glycol, trimethylene glycol, tetramethylene glycol, pentamethylene glycol, hexamethylene glycol, hexylene glycol and the like are known. As a combination of these polymerization components, a particularly chemically stable copolymer of terephthalic acid and ethylene glycol can be used. From the viewpoint of process suitability of the base material, it is desirable that the polyester film made of the copolymer is at least uniaxially stretched, and "Tetron film" (manufactured by Teijin DuPont Film Co., Ltd., trade name) is commercially available. ) And "Lumirror" (manufactured by Toray Industries, Inc., trade name) can be used for biaxially stretched films.

次いで、このフィルム21の一方の表面には、未延伸ポリエステル繊維を含む繊維ウエブを熱接着し、単位面積当たりの結晶化熱が3.0×10−2J/cm以下である不織布層23が設けられる。このうち、不織布層23の一原料となる未延伸ポリエステル繊維も、上述したポリエステルフィルムと実質的に同一の樹脂原料とするのが好ましい。また、この繊維ウエブには、未延伸ポリエステル繊維を35〜60質量%含むのが好ましく、残る構成繊維は、当該未延伸ポリエステル繊維を加熱結晶化した後の樹脂組成と実質的に同等なポリエチレンテレフタレート(PET)繊維とするのが良い。係るPET繊維として、例えば「ダクロン」(デュポン社製,商品名)や「テトロン」(東レ(株)製、商品名)として入手可能な延伸PET繊維が好適である。 Next, a fiber web containing unstretched polyester fibers is heat-bonded to one surface of the film 21, and a non-woven fabric layer 23 having a heat of crystallization of 3.0 × 10-2 J / cm 2 or less per unit area is formed. It is provided. Of these, it is preferable that the unstretched polyester fiber, which is one raw material of the non-woven fabric layer 23, is also a resin raw material substantially the same as the polyester film described above. Further, it is preferable that the fiber web contains 35 to 60% by mass of undrawn polyester fibers, and the remaining constituent fibers are polyethylene terephthalate having substantially the same resin composition as the resin composition after the undrawn polyester fibers are heat-crystallized. It is better to use (PET) fiber. As such PET fiber, for example, drawn PET fiber available as "Dacron" (manufactured by DuPont, trade name) or "Tetron" (manufactured by Toray Industries, Inc., trade name) is preferable.

本発明では特許文献2の技術を応用し、フィルム21に設けられた不織布層23とは異なる他方の面にラミネートフィルム31を配して基材33を構成する。このラミネートフィルム31としては、ポリエステル製のフィルム21よりも透湿性の低い、環状オレフィン系コポリマー樹脂と低密度ポリエチレン樹脂とをブレンドした単層フィルム(以下、COC/PE−LDと略記)、ポリエチレン樹脂からなる単層フィルム(以下、PEと略記)、ポリ塩化ビニリデン樹脂からなる単層フィルム(以下、PVDCと略記)、低密度ポリエチレン樹脂と直鎖状低密度ポリエチレン樹脂とを積層構成した複合フィルム(以下、PE−LD+PE−LLDと略記)、或いは上述した何れかの熱可塑性樹脂をベースフィルムとして、アルミ蒸着や酸化アルミ蒸着を施したものなどから任意好適に選択することができる。 In the present invention, the technique of Patent Document 2 is applied, and the laminate film 31 is arranged on the other surface different from the non-woven fabric layer 23 provided on the film 21 to form the base material 33. The laminated film 31 includes a single-layer film (hereinafter abbreviated as COC / PE-LD), which is a blend of a cyclic olefin-based copolymer resin and a low-density polyethylene resin, which has lower moisture permeability than the polyester film 21, and a polyethylene resin. Single-layer film made of (hereinafter abbreviated as PE), single-layer film made of polyvinylidene chloride resin (hereinafter abbreviated as PVDC), composite film composed of a low-density polyethylene resin and a linear low-density polyethylene resin laminated (hereinafter abbreviated) Hereinafter, it is abbreviated as PE-LD + PE-LLD), or any of the above-mentioned thermoplastic resins can be arbitrarily selected from those subjected to aluminum vapor deposition or aluminum oxide vapor deposition as a base film.

また、ラミネートフィルムの透湿度は、当然、フィルムの構成樹脂によっても異なるが、一般に厚いほど透湿度は低くなり、ODT効果への寄与は大きくなる。一例としてPVDCの透湿度は、フィルムの厚さ15μmでは1.0(g/m/日)、厚さ25μmの場合には0.6(g/m/日)、及び厚さ38μmの場合には0.4(g/m/日)となることが知られている。しかしながら、基材が所定の厚さを超える場合には貼付薬の端部に加わる力によって、基材自体に剥離を来すなどの虞がある。従って、ラミネートフィルムの厚さは、貼り合わせにおけるピンホール発生の回避や工程内で加わるフィルム張力を考慮した加工適性を満足するため10μm以上、より好ましくは15μm以上とし、上記剥離を防ぐため25μm以下とするのが好ましい。 Further, the moisture permeability of the laminated film naturally differs depending on the constituent resin of the film, but in general, the thicker the film, the lower the moisture permeability and the greater the contribution to the ODT effect. As an example, the moisture permeability of PVDC is 1.0 (g / m 2 / day) when the film thickness is 15 μm, 0.6 (g / m 2 / day) when the film thickness is 25 μm, and 38 μm. In some cases, it is known to be 0.4 (g / m 2 / day). However, if the base material exceeds a predetermined thickness, the base material itself may be peeled off due to the force applied to the end portion of the patch. Therefore, the thickness of the laminated film is 10 μm or more, more preferably 15 μm or more, and 25 μm or less to prevent the peeling, in order to avoid the occurrence of pinholes in the bonding and to satisfy the processing suitability in consideration of the film tension applied in the process. Is preferable.

さらに、上述したラミネートフィルムをフィルム21の表面に貼り合わせるにあたっては、フィルム21に熱接着可能な樹脂成分を採用した、所謂、熱ラミネート法、或いは種々のホットメルト樹脂をスプレー状に被着した後に貼り合わせる方法、熱溶融した樹脂を所定の厚さに押し出し、直接フィルムとして貼り付けるダイレクトラミネート法、フィルム21に予めプラズマ処理を施して積層接着強度を上げる手法など、周知の技術を適用することができる。 Further, when the above-mentioned laminated film is attached to the surface of the film 21, a so-called thermal laminating method in which a resin component that can be thermally adhered to the film 21 is adopted, or after various hot melt resins are applied in a spray form. Well-known techniques can be applied, such as a method of laminating, a direct laminating method of extruding a heat-melted resin to a predetermined thickness and directly pasting it as a film, and a method of preliminarily applying plasma treatment to the film 21 to increase the laminating adhesive strength. it can.

このように構成された本発明の貼付薬用基材は、KES-FB2法による数値関係から理解できるように、前述した凹型カールを生じやすい方向に曲げ固く、これとは相対する方向に曲げる力が小さな値を示すことになる。従って、本発明に言う「凹型応力が凸型応力よりも大きい」とは、前述凹型のカールを生じにくい状態を表しており、粘着剤を塗布形成した後に前述の「凹型カール」を生じる傾向が低い。 As can be understood from the numerical relationship by the KES-FB2 method, the patch medicated base material of the present invention configured in this way is bent and hard in the direction in which the above-mentioned concave curl is likely to occur, and the force of bending in the direction opposite to the concave curl is strong. It will show a small value. Therefore, "the concave stress is larger than the convex stress" in the present invention represents a state in which the above-mentioned concave curl is unlikely to occur, and the above-mentioned "concave curl" tends to occur after the adhesive is applied and formed. Low.

以下、本発明の好適形態を適用した実施例と、背景技術を適用した比較例とを評価した結果について説明する。 Hereinafter, the results of evaluating an example to which the preferred embodiment of the present invention is applied and a comparative example to which the background technology is applied will be described.

(実施例1及び比較例1)
始めに、評価に用いた各種基材について説明すれば、市販のポリエチレンテレフタレート(以下、PETと略記する場合がある)からなる、厚さ12.0(μm)、面密度16.8(g/m)の2軸延伸フィルムを準備した。このフィルムに熱接着する繊維ウエブとして、未延伸PET繊維(繊度4.0(デシテックス)×繊維長38(mm))と延伸PET繊維(繊度1.3(デシテックス)×繊維長38(mm))とを質量比40:60に混綿してフラットカード機でウエブ形成した。これら繊維ウエブとフィルムとの熱接着は、195(℃)とした金属ロールと弾性ロールからなるカレンダーにより、線圧30(kg/cm)、生産速度5(m/分)で行ない、上述したフィルムに面密度12(g/m)の不織布層を設けた厚さ50(μm)の比較例1の複合不織布層(基材)を得た。次いで、この比較例1に係る複合不織布層のPETフィルム面に、アクリルゴム系樹脂からなるホットメルト樹脂を約2(g/m)の塗布量となるようにスプレーで施し、市販のPVDCフィルム(厚さ25μm)を積層圧着することによってラミネートフィルムを配し、実施例1に係る基材とした。
(Example 1 and Comparative Example 1)
First, the various base materials used for the evaluation will be described. The thickness is 12.0 (μm) and the surface density is 16.8 (g / g / g /), which is made of commercially available polyethylene terephthalate (hereinafter, may be abbreviated as PET). It was prepared biaxially stretched film of m 2). Undrawn PET fibers (fineness 4.0 (decitex) x fiber length 38 (mm)) and drawn PET fibers (fineness 1.3 (decitex) x fiber length 38 (mm)) are used as fiber webs that heat-adhere to this film. And were mixed at a mass ratio of 40:60 to form a web with a flat card machine. The thermal adhesion between these fiber webs and the film was performed at a linear pressure of 30 (kg / cm) and a production rate of 5 (m / min) using a calendar composed of a metal roll and an elastic roll at 195 (° C.), and the above-mentioned film was formed. A composite non-woven fabric layer (base material) of Comparative Example 1 having a thickness of 50 (μm) provided with a non-woven fabric layer having a surface density of 12 (g / m 2 ) was obtained. Next, a hot melt resin made of an acrylic rubber resin was sprayed onto the PET film surface of the composite non-woven fabric layer according to Comparative Example 1 so as to have a coating amount of about 2 (g / m 2 ), and a commercially available PVDC film was applied. A laminated film was arranged by laminating and crimping (thickness 25 μm) to obtain a base material according to Example 1.

(実施例2〜実施例4)
上述の実施例1におけるラミネートフィルムに代えて、厚さ15μmのPVCDフィルム(実施例2)、COC/PE−LDの溶融樹脂を20μmの厚さに調整したフィルム(実施例3)、厚さ25μmの市販のPEフィルム(実施例4)を用い、各々、基材とした。
(Examples 2 to 4)
Instead of the laminated film in Example 1 described above, a PVCD film having a thickness of 15 μm (Example 2), a film prepared by adjusting the molten resin of COC / PE-LD to a thickness of 20 μm (Example 3), and having a thickness of 25 μm. Commercially available PE film (Example 4) was used as a base material.

(実施例5〜実施例6)
比較例1に係る複合不織布層のPETフィルム面にPE−LD+PE−LLDの溶融樹脂を15μm厚さになるように直接ラミネートした基材(実施例5)、並びにPE−LD+PE−LLDの溶融樹脂を厚さ20μmの厚さになるように直接ラミネートした基材(実施例6)を用い、基材とした。
(Examples 5 to 6)
A base material (Example 5) in which a molten resin of PE-LD + PE-LLD was directly laminated on the PET film surface of the composite non-woven fabric layer according to Comparative Example 1 so as to have a thickness of 15 μm, and a molten resin of PE-LD + PE-LLD were applied. A base material (Example 6) directly laminated so as to have a thickness of 20 μm was used as a base material.

(比較例2及び比較例3)
比較例1とは、繊維ウエブの目付のみが異なる比較例2(繊維ウエブの目付18g/m)並びに比較例3(繊維ウエブの目付30g/m)を得た。
(Comparative Example 2 and Comparative Example 3)
Comparative Example 2 (fiber web basis weight 18 g / m 2 ) and Comparative Example 3 (fiber web basis weight 30 g / m 2 ), which differed only from Comparative Example 1 in the basis weight of the fiber web, were obtained.

(透湿度の測定)
これら実施例1〜実施例6、並びに比較例1〜3の各基材について、JIS L 1099 2012の7.1.1「塩化カルシウム法(A―1法)」に準じて透湿度を測定した。まず、各基材を直径98mmの円形に裁断する。予め約40℃に調製したアルミ製の円筒状透湿カップ(内径60mm、外径90mm、高さ22mm)に、吸湿剤となる塩化カルシウムをカップ上端に3mmのスペースが生じるように平坦に収容し、秤量した。次いで、この透湿カップの上端を評価対象である基材で覆い、パッキン等を使用して円筒状透湿カップを密閉し、試験体とした。この状態の試験体を、人体に貼付した状態に近い温度40℃、相対湿度90%の条件に保つ恒温恒湿装置内に容れて1時間静置し、取り出して秤量した。この秤量値を記録した後、再度、上記恒温恒湿装置内に1時間静置して2度目の秤量を行った。各基材に関して、このような2回の秤量値を記録した。この秤量値のうち、下記の式に示すように、測定開始後1時間経過後の1回目の秤量値をa(g)、測定開始後2時間経過した時点の2回目の秤量値をa(g)とし、これら秤量値の差を透湿面積S(m)で除し、24時間あたりの透湿量に換算することで透湿度P(g/m/日)とした。
P=[(a−a)/S]×24
(Measurement of moisture permeability)
The moisture permeability of each of the base materials of Examples 1 to 6 and Comparative Examples 1 to 3 was measured according to 7.1.1 "Calcium chloride method (A-1 method)" of JIS L 1099 2012. .. First, each base material is cut into a circle having a diameter of 98 mm. Calcium chloride, which is a hygroscopic agent, is stored flat in an aluminum cylindrical moisture-permeable cup (inner diameter 60 mm, outer diameter 90 mm, height 22 mm) prepared in advance at about 40 ° C. so as to create a space of 3 mm at the upper end of the cup. , Weighed. Next, the upper end of the moisture permeable cup was covered with a base material to be evaluated, and the cylindrical moisture permeable cup was sealed using packing or the like to prepare a test piece. The test piece in this state was placed in a constant temperature and humidity device kept at a temperature of 40 ° C. and a relative humidity of 90%, which was close to the state of being attached to a human body, allowed to stand for 1 hour, taken out and weighed. After recording this weighing value, the device was allowed to stand in the constant temperature and humidity device for 1 hour again to perform the second weighing. For each substrate, such two weighing values were recorded. Of these weighed values, as shown in the following formula, the first weighed value 1 hour after the start of measurement is a 1 (g), and the second weighed value 2 hours after the start of measurement is a. 2 (g), and the difference between these weighing values was divided by the moisture permeation area S (m 2 ) and converted into the moisture permeation amount per 24 hours to obtain the moisture permeation P (g / m 2 / day).
P = [(a 2- a 1 ) / S] × 24

(KES−FB2の測定)
市販の純曲げ試験機(KES−FB2,カトーテック(株)製)を用いて、20cm角に裁断した各基材を[曲率K=―2.5〜2.5cm−1]、[変形速度0.5cm−1/秒]の条件で単位長さ当たりの曲げ剛性を各3回測定した。得られたチャートから、基材の不織布面側に曲げた際の曲げ剛性の最大値を『凸型応力』、ラミネートフィルム(又はフィルム)面側に曲げた際の最大値を『凹型応力』として、各々の平均値で求めた。
上述した各評価用基布の構成、透湿度、KES−FB2の測定結果を[表1]に示す。

(Measurement of KES-FB2)
Using a commercially available pure bending tester (KES-FB2, manufactured by Kato Tech Co., Ltd.), each base material cut into 20 cm squares was cut into 20 cm squares [curvature K = -2.5 to 2.5 cm -1 ], [deformation speed]. The flexural rigidity per unit length was measured 3 times each under the condition of [0.5 cm -1 / sec]. From the obtained chart, the maximum value of flexural rigidity when bent toward the non-woven fabric surface side of the base material is defined as "convex stress", and the maximum value when bent toward the laminated film (or film) surface side is defined as "concave stress". , Obtained by the average value of each.
[Table 1] shows the composition of each evaluation base cloth, the moisture permeability, and the measurement results of KES-FB2 described above.

Figure 0006803789
Figure 0006803789

この表1から理解できるように、本発明を適用し、ラミネートフィルムを配した各実施例では、各比較例に較べて凸型応力が比較的低く、このラミネートフィルムを内側にしたカールを生じさせるためにより大きな外力を要する傾向が確認できた。このことから、本発明の基材を用いて薬効成分を塗膏した貼付薬では、凹型カールによる、貼付対象からの剥離解消を期待し得ることが理解できる。また、各実施例と各比較例との比較から、複合不織布層に含まれるPETフィルム単独の場合に較べ、何れの実施例でも透湿度の低減を図ることができる。特に実施例5と比較例3とは同一の基材目付であるが、本発明の構成を採用することによって、およそ2分の1の透湿度を達成しており、ODT効果を有効に発揮させ得ることが理解できる。 As can be understood from Table 1, in each example in which the present invention is applied and a laminated film is arranged, the convex stress is relatively low as compared with each comparative example, and curls are generated with the laminated film inside. Therefore, it was confirmed that a larger external force was required. From this, it can be understood that the patch coated with the medicinal ingredient using the base material of the present invention can be expected to eliminate the peeling from the sticking target due to the concave curl. Further, from the comparison between each example and each comparative example, it is possible to reduce the moisture permeability in any of the examples as compared with the case where the PET film contained in the composite non-woven fabric layer is used alone. In particular, although Example 5 and Comparative Example 3 have the same basis weight, by adopting the configuration of the present invention, about half the moisture permeability is achieved, and the ODT effect is effectively exhibited. Understand what you get.

11:不織布、13:樹脂シート、15:不織布積層体、17:粘着剤層、21:(ポリエステル)フィルム、23:不織布層、25:複合不織布層(基材)、27:粘着剤、31:ラミネートフィルム、33:基材。

11: Non-woven fabric, 13: Resin sheet, 15: Non-woven fabric laminate, 17: Adhesive layer, 21: (Polyester) film, 23: Non-woven fabric layer, 25: Composite non-woven fabric layer (base material), 27: Adhesive, 31: Laminated film, 33: Substrate.

Claims (1)

厚さが6〜25μmのポリエチレンテレフタレートフィルムの一方の表面に、未延伸ポリエステル繊維を含む繊維ウエブを熱接着してなる不織布層が設けられた複合不織布層を含み、かつ該複合不織布層の単位面積当たりの結晶化熱が3.0×10−2J/cm以下である貼付薬用基材であって、
前記フィルムの他方の面にラミネートフィルムを配し、
前記ラミネートフィルムは、環状オレフィン系コポリマー樹脂と低密度ポリエチレン樹脂とをブレンドした単層フィルム、ポリエチレン樹脂からなる単層フィルム、ポリ塩化ビニリデン樹脂からなる単層フィルム、低密度ポリエチレン樹脂と直鎖状低密度ポリエチレン樹脂とを積層構成した複合フィルムから選択される、厚さが25μm以下のラミネートフィルムであって、
KES法の純曲げ試験(KES−FB2法)で求めた凹型応力が凸型応力よりも大きいことを特徴とする貼付薬用基材であって、
温度40℃、相対湿度90%における透湿度が40(g/m /日)以下であることを特徴とする貼付薬用基材。
A composite non-woven fabric layer provided with a non-woven fabric layer formed by heat-bonding a fiber web containing unstretched polyester fibers is provided on one surface of a polyethylene terephthalate film having a thickness of 6 to 25 μm , and the unit area of the composite non-woven fabric layer. A patched medicinal substrate having a heat of crystallization of 3.0 × 10-2 J / cm 2 or less.
A laminated film is placed on the other side of the film,
The laminated film is a single layer film in which a cyclic olefin copolymer resin and a low density polyethylene resin are blended, a single layer film made of a polyethylene resin, a single layer film made of a polyvinylidene chloride resin, a low density polyethylene resin and a linear low density film. A laminated film having a thickness of 25 μm or less, which is selected from a composite film formed by laminating a density polyethylene resin.
It is a patch medicinal base material characterized in that the concave stress obtained by the pure bending test (KES-FB2 method) of the KES method is larger than the convex stress .
A patch medicinal base material having a moisture permeability of 40 (g / m 2 / day) or less at a temperature of 40 ° C. and a relative humidity of 90% .
JP2017066487A 2017-03-30 2017-03-30 Patch medicated base material Active JP6803789B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2017066487A JP6803789B2 (en) 2017-03-30 2017-03-30 Patch medicated base material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2017066487A JP6803789B2 (en) 2017-03-30 2017-03-30 Patch medicated base material

Publications (3)

Publication Number Publication Date
JP2018168090A JP2018168090A (en) 2018-11-01
JP2018168090A5 JP2018168090A5 (en) 2019-12-26
JP6803789B2 true JP6803789B2 (en) 2020-12-23

Family

ID=64018359

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017066487A Active JP6803789B2 (en) 2017-03-30 2017-03-30 Patch medicated base material

Country Status (1)

Country Link
JP (1) JP6803789B2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10316558A (en) * 1997-05-21 1998-12-02 Sekisui Chem Co Ltd Patch support
JP2005343125A (en) * 2004-06-07 2005-12-15 Idemitsu Unitech Co Ltd Non-woven fabric laminate and skin patch
JP2006230930A (en) * 2005-02-28 2006-09-07 Alcare Co Ltd Pasting material
JP5033602B2 (en) * 2006-12-04 2012-09-26 日本バイリーン株式会社 Composite nonwoven fabric for patches
JP6368222B2 (en) * 2014-10-31 2018-08-01 日本バイリーン株式会社 Patch support and patch

Also Published As

Publication number Publication date
JP2018168090A (en) 2018-11-01

Similar Documents

Publication Publication Date Title
JP5421379B2 (en) Thin film nasal dilator with delivery system
US11246761B2 (en) Conformable wound dressing and delivery system
JP5756029B2 (en) Tape preparation
AU4463499A (en) Film-based bandage material
RU2428157C2 (en) Medical or technical product for attachment to skin or component for attaching medical product or its part to skin, possessing removable protective layer
CA2910570C (en) Multi-layered assembly with tight peel control
KR20050044656A (en) Transdermal therapeutic system provided with improved long-term carrying comfort
US8267880B2 (en) Elastic bandage segment
JP6803789B2 (en) Patch medicated base material
CN102316860B (en) Film substrate for adhesive material and adhesive material
JP5033602B2 (en) Composite nonwoven fabric for patches
KR101153752B1 (en) Adhesive preparation adhesive preparation
JP2002248124A (en) Medical patches and emergency bandages
JP2004216098A (en) Adhesive sheet or tape
JP5951176B2 (en) Dressing material
JP2021104980A (en) Patch support body and patch
JP2008037798A (en) Skin patch sheet
JP4318606B2 (en) Manufacturing method of patch
JPH0892076A (en) Percutaneous absorption-type plaster
JPWO2017018315A1 (en) Reinforcing tape for skin suturing or after skin suturing
JP2022180225A (en) Film for bonding to biological tissue and transfer sheet
JP3345175B2 (en) Transdermal drug support
JP2023075797A (en) Biological tissue sticking film and transfer sheet
JP2020175573A (en) Transfer laminate and transfer method of transfer laminate
JP2020130726A (en) Medical patch using elastic pad

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191112

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20191112

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200908

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201015

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20201124

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20201201

R150 Certificate of patent or registration of utility model

Ref document number: 6803789

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150